Nuvation Bio Inc.
NUVB
$8.18
$0.719.44%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 59.14% | 60.27% | -780.50% | -649.24% | -542.39% |
| Total Depreciation and Amortization | 173.41% | 154.13% | 317.41% | 207.66% | 140.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -91.32% | -92.56% | 5,535.32% | 6,281.91% | 3,778.52% |
| Change in Net Operating Assets | -72.87% | 111.40% | -36.31% | -2,416.11% | -432.66% |
| Cash from Operations | -91.64% | -99.73% | -144.42% | -91.79% | -43.39% |
| Capital Expenditure | -34.04% | -525.81% | -146.43% | -134.78% | -55.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 133.33% |
| Cash Acquisitions | -100.73% | -100.73% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -29.64% | 259.88% | 129.28% | 1,130.36% | 299.64% |
| Cash from Investing | -38.32% | 190.50% | 147.36% | 1,275.44% | 325.94% |
| Total Debt Issued | 674.34% | 674.34% | -- | -- | -- |
| Total Debt Repaid | 12.56% | -82.55% | -- | -- | -- |
| Issuance of Common Stock | 6.45% | 131.07% | 1,594.02% | 677.87% | 320.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14,228.05% | 6,357.62% | 144.44% | -47.29% | 47.65% |
| Foreign Exchange rate Adjustments | 262.05% | 410.26% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,120.72% | 1,454.15% | 203.38% | 88.15% | 104.94% |